R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins. It’s the first part of what the company describes will grow to become a ...
Some subscribers prefer to save their log-in information so they do not have to enter their User ID and Password each time they visit the site. To activate this function, check the 'Save my User ID ...
R&D software developer Accelrys ($ACCL) has spent the four years since it merged with Symyx gobbling up a string of smaller companies. Yet this week Accelrys ...
Growth investor New Mountain Capital invested in Cytel Inc., which provides analytical software and services to the life-sciences industry, according to a news release. Financial terms of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results